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1. Introduction 
There is little doubt, despite some contradictory 
reports, that the liver is a main target of prostaglandin 
El (PGEI ). The PGEl -due increase of cyclic-AMP 
levels occurring when the drug is injected into rats [l] 
or when it is added to isolated rat liver hepatocytes 
[2] has been fully accounted for by a stimulatory 
effect on adenylate cyclase of particulate liver frac- 
tions [ 1 ] and isolated liver plasma membranes as well 
[3]. Using liver plasma membranes we have shown 
that a PGEl -sensitive cyclase is clearly distinct from 
glucagon and epinephrine-sensitive cyclases [3] ; in 
several tissues moreover PGEl action appears to be 
best explained by assuming an interaction with a 
specific receptor that does not share any property 
with polypeptide hormone or catecholamines receptors 
t4,51* 
In order to distinguish whether PGEl has to be 
considered an intercellular or an intracellular messenger 
it was important in our opinion to establish whether 
PGEl receptor is on the outer or on the inner layer of 
the plasma membrane. Experiments carried out in 
isolated hepatocytes point to an external rather than 
to an internal localization of PGEl receptor, thus 
favouring a role of PGEl as intercellular messenger 
[41. 
The results of experiments reported here, which 
indicate that PGEl dramatically increases cyclic-AMP 
levels in a discrete hepatocyte population not involving 
parenchymal cells, give a strong support to the role of 
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PGEl as intercellular regulator of cyclic AMP. While 
this work was in progress Wincek et al. [6] separated 
Kupffer cells from parenchymal cells after collagenase 
digestion of the liver and observed that PGEl -sensitive 
cyclase is anatomically separated from glucagon 
sensitive cyclase, the former being present largely in an 
endothelial rich cellular fraction (and absent from 
Kupffer cells) and the latter being present just in 
parenchymal cells. 
2. Materials and methods 
2.1. Determination of cyclic-AMP levels in isolated 
hepatocytes 
Hepatocytes were isolated according to the Seglen’s 
modification [7] of the Berry and Friend [8] method, 
using fed male Wistar rats 200-250 g in weight, as 
previously described [9]. Hepatocytes suspended in 
Krebs-Ringer bicarbonate buffer (PH 7.4) containing 
2.5 mM calcium and 2% bovine serum albumin, at 
the concentration of 1 O-20 mg protein/ml, were 
incubated in test tubes in a shaking bath at 30°C for 
5 min. Reactions were blocked by centrifugation at 
low speed in the cold and by addition of 1 ml of 5% 
cold TCA to the sediments. On TCA-free supernatants 
cyclic AMP was assayed according to the method of 
Brown et al. [lo] as previously described [9] . 
2.2. Fractionation of isolated hepatocytes 
In a first series of experiments hepatocytes were 
subjected to the fractionation procedure described by 
Drochmans et al. [l l] employing a continous Ficoll 
gradient containing EDTA and albumin. After 3 h of 
centrifugation at 62 500 X g most of the cells were 
found at the bottom of the tube and only a minor 
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part was recovered close to the top of the-tube. 
Owing to the low‘yield and variability of the results 
we tried the aqueous two-phase system obtained by 
mixing Dextran T 500 with polyethylene glycol, as 
described by Albertson [ 121. We were unable to 
achieve a separation of liver cells since all of the 
material added partitioned at the interface. 
Satisfactory results were finally obtained employ- 
ing centrifugation on discontinuous Ficoll density 
gradients. Solutions of Ficoll dissolved in Krebs- 
Ringer containing 2 mM EDTA and 2% albumin were 
layered in S. W. 25.1 Spinco tubes. The gradient was 
formed immediately before use by layering 40%, 37%, 
30% and 15% Ficoll solutions (5 ml each), 5 ml of 
hepatocyte suspension in Krebs-Ringer were layered 
at the top and tubes were centrifuged at 62 500 X g 
for 60 min. Four layers of cells were observed: fraction 
I between 15 and 30%, fraction II between 30 and 37%, 
fraction III between 37 and 40% and fraction IV at 
the bottom of the tube. The fractions were collected 
by a Pasteur pipette, diluted with Krebs-Ringer and 
washed free of Ficoll by centrifuging two times at 
low speed. Hepatocyte fractions were finally 
suspended in Krebs-Ringer (5-10 mg proteins/ml) and 
used for assays. A further liver fraction designed 
‘hepatocyte wash’ was obtained by collecting super- 
natants of whole liver cells suspension centrifuged at 
50 X g (see ref. [9]). 
Rostaglandins were a gift of Dr J. Pike, the Upjohn 
Co. Kalamazoo, USA. Glucagon (insulin free) was 
from E. Lilly Co. Indianapolis, USA. Labeled cyclic 
AMP (27 Ci/mmol) was a product of Radiochemical 
Centre England. Ficoll was a product of Pharmacia 
Uppsala, Sweden. 
3. Results 
The observation that glucagon stimulates about 
1 O-fold adenylate cyclase of liver plasma membranes 
and increases cyclic AMP levels from 8-l 5-fold in 
isolated hepatocytes while PGEi stimulates the 
enzyme 6-8-fold but increases cyclic AMP only 
1.5-3-fold [3,4], lead us to investigate whether 
some change in the liver cellular population distribu- 
tion occurred passing from the whole organ (from 
which plasma membrane is isolated) to the suspension 
of liver cells we generally employed. It turned out 
that after digestion of the liver with collagenase the 
mechanically dispersed cells are subjected - as pre- 
scribed by the Berry and Friend method [8] - to a 
low-speed centrifugation which sediments the heavier 
parenchymal cells leaving most of the non-paren- 
chymal light cells in the supernatant. However a 
microscopical examination showed that the paren- 
chymal cell-rich sediment contained from 4-6% of 
non-parenchymal cells, which were on the other hand 
abundant in the supernatant. Therefore it was importam 
to investigate the effect of glucagon and PGEr on rela- 
tively homogeneous cellular populations. The use of 
discontinuous Ficoll density gradient enabled us to 
isolate parenchymal cells completely free from non- 
parenchymal elements. When the four gradient fractions 
were examined at microscope it was observed that the 
lightest fraction I which constituted 6.2 + 2.5% of 
total cellular proteins included non-parenchymal cells 
only (table 1). In table 1 it is shown that optimal 
doses of glucagon produced a modest increase of 
cyclic AMP while the PGEr -due increase was six fold. 
Fraction II (13.6 f 6.5% of total cells) was constituted 
mainly by parenchymal cells containing less than 2% 
of non-parenchymal elements. When added to this 
fraction glucagon very effectively increased cyclic 
AMP while PGEr effect was not significantly different 
from control. Fraction III (10.0 + 3.7% of total cells), 
a homogeneous population of parenchymal cells 
behaved similarly to fraction II. In the major part of 
cells sedimenting at the bottom of the tube, basal 
cyclic AMP levels were lower than those of the 
lighter fractions and glucagon was less effective 
probably because part of the cells were damaged. 
In fig.1 a dose response study of the effect of 
glucagon and PGE on parenchymal and non paren- 
chymal cells is reported. The K, (half-maximal 
stimulating dose) for glucagon was 2 X 10T8 M a 
value which compares well with that obtained with 
plasma membrane adenylate cyclase [4], the K, 
for PGEr was 2 X 10m7 M, about one order of 
magnitude lower than that found using plasma mem- 
branes [4]. This is not surprising if one considers 
that liver is constituted by more than 70% of paren- 
chymal cells and it is likely therefore that about 30% 
of isolated membranes are of non-parenchymal 
nature. PGEz as expected was found to be-less 
effective than PGEi . 
In fig.2 a time-course study depicting glucagon and 
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Table 1 
Cyclic AMP control by glucagon and PGE, in hepatocyte fractions isolated by FicoII density gradient 
Gradient fraction I II III IV Hepatocyte wash 
Control 12.2+- 2.0 9.3 f. 2.3 7.3 f 1.3 5.1 + 1.4 7.1 + 1.8 
(4) (3) (3) (3) (3) 
Glucagon 24.2 + 4.9 65.9 * 25.0 75.1 + 12.0 27.6 t 3.3 14.2 + 2.9 
(4)a (3)a (3)a (3)b (3)c 
PGE, 69.0 + 14.1 15.5 f 3.8 9.1 r 1.4 7.2 * 2.4 53.6 + 18.0 
(4)b (3)c (3)c (3)c (3)a 
% of total proteins 6.2+ 2.5 13.6 +_ 6.5 10.0* 3.7 70.0 f 2.6 
For experimental conditions see under Materials and methods. Data are means + S.E. of the experiments reported in parentheses 
and represent pmoles cyclic AMP/mg protein. Glucagon was 0.1 PM and PGE, 2.5 pg/ml. 
a p < 0.05 with respect to control. 
b p < 0.005 with respect to control. 
’ Not significantly different. 
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Fig.1. Dose-response curve regarding cyclic AMP control by ghrcagon and PGE on parenchymal and non parenchymal cells 
respectively. Incubations were carried out for 5 min at 30°C as described under Materials and methods using standard hepatocyte 
preparations when glucagon (10-‘0-10-6 M) was tested and the ‘hepatocyte wash’ constituted mainly by non-parenchymal cells 
- Kupffer, endothelial cells and erythrocytes - when PGE (2.5 X 10-v - 2.5 X lo-$ M) were tested. Each point represents the 
mean of 3 determinations. 
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Fig.2. Time-course curves regarding cyclic AMP control by 
glucagon and PGE, on parenchymal and non parenchymal 
cells respectively. Glucagon effect (1 PM) was tested using 
standard hepatocyte preparations (X-X). PGE, (2.5 Ng/ml) 
was tested on the ‘hepatocyte wash’ (o-o) as well as on 
Ficoll density gradient fraction I (e-o). Each point 
represents the mean of 3 experiments and bars represent S.E. 
of 6 determinations. 
PGEi action on hepatocytes is shown. Glucagon at 
30°C produced a maximum increase of cyclic AMP 
yet after 30 s of incubation, afterwards the nucleotide 
level rapidly declined reaching the control value after 
45 mln of incubation. PGEi was tested on the fraction 
called hepatocyte wash and on gradient fraction I. In 
the former case PGEr action was less rapid than that 
due to glucagon, but cyclic AMP increase is dramatic 
and persistent up to 60 min, the longest incubation 
time tested. PGEr elevated cyclic AMP level about 
20-fold when added to hepatocyte wash and about 
5-fold when added to fraction I, namely to a relative 
homogeneous Kupffer cells population. This indicates 
that the target of PGEi action is probably a liver 
cellular fraction distinct from parenchymal and 
Kupffer cells. 
4. Discussion 
The findings reported here, as well as those of 
Wincek et al. [6] may help to unravel some unex- 
plained findings in the area of the mechanism of PGEr 
action at least in the liver. The decreased sensitivity 
to PGEi observed when comparing adenylate cyclase 
of liver plasma membrane to cyclic AMP levels of 
isolated hepatocytes has to be explained by a loss of 
non-parenchymal, PGEr -sensitive cells when isolating 
hepatocytes by currently used techniques. 
The preferential action of PGEr on non-paren- 
chymal cells may account for the observation that 
PGEr , unlike glucagon, does not modify or even 
inhibit gluconeogenesis in the perfused rat liver [ 131 
or in isolated rat liver cells [ 141. In addition the 
glycogenolytic effect of PGEi is considerably less 
pronounced than that of glucagon [2]. 
The findings of Wincek et al. [6] are only in part in 
agreement with ours but it has to be underlined that 
they assayed effects on adenylate cyclase of particulate 
fractions while we measured variations of cyclic AMP 
levels. Although they found a glucagon stimulation of 
about 1 O-fold in accordance with our data, they never 
observed a PGEr stimulation over 3-4-fold, which 
compares with the 20-fold increase we observed using 
the same hepatocyte wash used by Wincek et al. [6]. 
Secondly they interpreted the data as indicating that 
PGEi -sensitive cyclases are present in endothelial cells 
as well as in parenchymal cells. Our results on the 
other hand show that PGEi has no significant effect 
on cyclic AMP of parenchymal cells. While the first 
discrepancy is difficult to explain, the second one may 
well be due to the extent of contamination of paren- 
chymal cells. We observed that gradient fractions as 
III or IV (see table 1) unresponsive to PGEr contained 
less than 1% of non-parenchymal elements. We agree 
with Wincek et al. that PGEr receptor should be 
present in sinusoids-lining endothelial cells rather than 
in Kupffer cells. 
Since the function of liver endothelial cells is 
poorly understood [ 1.51 it is hazardous to speculate 
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about the functional significance of the PGEr induced 
cyclic AMP elevation. The fact that cyclic AMP 
increase persisted for at least 1 h while glucagon effect 
on parenchymal cells is much more transitory, may 
suggest hat unlike glucagon which behaves mainly as 
a metabolic regulator, PGEr may act as a mitotic 
regulator, a function that it probably exerts in thymic 
lymphocytes [ 161 and in mast cells [ 171. Bourne et 
al. [ 171 have shown that PGE acting on mast cells 
are released from other cell types thus substantiating 
a role of PGE as intercellular messenger. A similar 
conclusion based on different arguments was reached 
by Bito [ 181 who considers prostaglandins as extra- 
cellular mediators. It is interesting that Minna and 
Gilman [ 191 studying the effect of PGE on a cell line 
of hepatic origin observed a dramatic increase in cyclic 
AMP level (69-fold). In addition the concentration and 
the time of exposure curves were very similar to ours. 
Experiments now in progress to find out which kind 
of liver cells are capable of synthesizing prostaglandins 
suggest hat the biosynthetic activity is restricted to 
non-parenchymal cells. 
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